nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolterodine—CYP2C19—Ifosfamide—testicular cancer	0.173	0.249	CbGbCtD
Tolterodine—CYP2C9—Ifosfamide—testicular cancer	0.144	0.207	CbGbCtD
Tolterodine—CYP3A4—Ifosfamide—testicular cancer	0.0837	0.12	CbGbCtD
Tolterodine—CYP2C9—Cisplatin—testicular cancer	0.07	0.101	CbGbCtD
Tolterodine—CYP2D6—Vinblastine—testicular cancer	0.0698	0.1	CbGbCtD
Tolterodine—CYP3A4—Vinblastine—testicular cancer	0.0444	0.0639	CbGbCtD
Tolterodine—CYP2D6—Doxorubicin—testicular cancer	0.0429	0.0617	CbGbCtD
Tolterodine—CYP3A4—Etoposide—testicular cancer	0.04	0.0575	CbGbCtD
Tolterodine—CYP3A4—Doxorubicin—testicular cancer	0.0273	0.0392	CbGbCtD
Tolterodine—Delusion—Ifosfamide—testicular cancer	0.00676	0.0222	CcSEcCtD
Tolterodine—Dementia—Methotrexate—testicular cancer	0.00552	0.0181	CcSEcCtD
Tolterodine—Infection—Carboplatin—testicular cancer	0.00498	0.0163	CcSEcCtD
Tolterodine—Disorientation—Bleomycin—testicular cancer	0.00454	0.0149	CcSEcCtD
Tolterodine—Pain—Carboplatin—testicular cancer	0.00429	0.0141	CcSEcCtD
Tolterodine—Disorientation—Ifosfamide—testicular cancer	0.00388	0.0127	CcSEcCtD
Tolterodine—Hallucination—Chlorambucil—testicular cancer	0.00361	0.0119	CcSEcCtD
Tolterodine—Urinary retention—Ifosfamide—testicular cancer	0.0033	0.0108	CcSEcCtD
Tolterodine—Anaphylactoid reaction—Cisplatin—testicular cancer	0.00309	0.0101	CcSEcCtD
Tolterodine—Angioedema—Chlorambucil—testicular cancer	0.00289	0.00948	CcSEcCtD
Tolterodine—Anaphylactoid reaction—Etoposide—testicular cancer	0.00283	0.00929	CcSEcCtD
Tolterodine—Dysuria—Ifosfamide—testicular cancer	0.00281	0.00921	CcSEcCtD
Tolterodine—Flushing—Bleomycin—testicular cancer	0.00261	0.00856	CcSEcCtD
Tolterodine—Vertigo—Vinblastine—testicular cancer	0.0026	0.00854	CcSEcCtD
Tolterodine—Confusional state—Chlorambucil—testicular cancer	0.0026	0.00853	CcSEcCtD
Tolterodine—Infection—Chlorambucil—testicular cancer	0.00256	0.00841	CcSEcCtD
Tolterodine—Flushing—Dactinomycin—testicular cancer	0.00243	0.00798	CcSEcCtD
Tolterodine—Hallucination—Ifosfamide—testicular cancer	0.00239	0.00784	CcSEcCtD
Tolterodine—Visual impairment—Ifosfamide—testicular cancer	0.00232	0.00759	CcSEcCtD
Tolterodine—Dyspepsia—Chlorambucil—testicular cancer	0.00227	0.00745	CcSEcCtD
Tolterodine—Flushing—Ifosfamide—testicular cancer	0.00223	0.00731	CcSEcCtD
Tolterodine—Fatigue—Chlorambucil—testicular cancer	0.00222	0.0073	CcSEcCtD
Tolterodine—Pain—Chlorambucil—testicular cancer	0.00221	0.00724	CcSEcCtD
Tolterodine—Feeling abnormal—Chlorambucil—testicular cancer	0.00213	0.00697	CcSEcCtD
Tolterodine—Gastrointestinal pain—Chlorambucil—testicular cancer	0.00211	0.00692	CcSEcCtD
Tolterodine—Chest pain—Bleomycin—testicular cancer	0.00208	0.00683	CcSEcCtD
Tolterodine—Influenza like illness—Epirubicin—testicular cancer	0.00206	0.00675	CcSEcCtD
Tolterodine—Abdominal pain—Chlorambucil—testicular cancer	0.00204	0.00669	CcSEcCtD
Tolterodine—Pain—Vinblastine—testicular cancer	0.00202	0.00663	CcSEcCtD
Tolterodine—Constipation—Vinblastine—testicular cancer	0.00202	0.00663	CcSEcCtD
Tolterodine—Confusional state—Bleomycin—testicular cancer	0.00201	0.0066	CcSEcCtD
Tolterodine—Oedema—Bleomycin—testicular cancer	0.002	0.00655	CcSEcCtD
Tolterodine—Anaphylactic shock—Bleomycin—testicular cancer	0.002	0.00655	CcSEcCtD
Tolterodine—Visual impairment—Cisplatin—testicular cancer	0.002	0.00655	CcSEcCtD
Tolterodine—Infection—Bleomycin—testicular cancer	0.00198	0.00651	CcSEcCtD
Tolterodine—Dry eye—Epirubicin—testicular cancer	0.00196	0.00642	CcSEcCtD
Tolterodine—Feeling abnormal—Vinblastine—testicular cancer	0.00195	0.00639	CcSEcCtD
Tolterodine—Gastrointestinal pain—Vinblastine—testicular cancer	0.00193	0.00634	CcSEcCtD
Tolterodine—Flushing—Cisplatin—testicular cancer	0.00192	0.0063	CcSEcCtD
Tolterodine—Angioedema—Ifosfamide—testicular cancer	0.00191	0.00627	CcSEcCtD
Tolterodine—Influenza like illness—Doxorubicin—testicular cancer	0.0019	0.00624	CcSEcCtD
Tolterodine—Hypersensitivity—Chlorambucil—testicular cancer	0.0019	0.00624	CcSEcCtD
Tolterodine—Vertigo—Ifosfamide—testicular cancer	0.00188	0.00616	CcSEcCtD
Tolterodine—Abdominal pain—Vinblastine—testicular cancer	0.00187	0.00613	CcSEcCtD
Tolterodine—Oedema—Dactinomycin—testicular cancer	0.00186	0.00611	CcSEcCtD
Tolterodine—Asthenia—Chlorambucil—testicular cancer	0.00185	0.00607	CcSEcCtD
Tolterodine—Infection—Dactinomycin—testicular cancer	0.00185	0.00607	CcSEcCtD
Tolterodine—Palpitations—Ifosfamide—testicular cancer	0.00185	0.00606	CcSEcCtD
Tolterodine—Abnormal vision—Epirubicin—testicular cancer	0.00185	0.00606	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Bleomycin—testicular cancer	0.00182	0.00597	CcSEcCtD
Tolterodine—Dry eye—Doxorubicin—testicular cancer	0.00181	0.00594	CcSEcCtD
Tolterodine—Arthralgia—Ifosfamide—testicular cancer	0.00178	0.00584	CcSEcCtD
Tolterodine—Chest pain—Ifosfamide—testicular cancer	0.00178	0.00584	CcSEcCtD
Tolterodine—Flatulence—Cisplatin—testicular cancer	0.00178	0.00583	CcSEcCtD
Tolterodine—Diarrhoea—Chlorambucil—testicular cancer	0.00177	0.00579	CcSEcCtD
Tolterodine—Flushing—Etoposide—testicular cancer	0.00176	0.00578	CcSEcCtD
Tolterodine—Hypersensitivity—Vinblastine—testicular cancer	0.00174	0.00571	CcSEcCtD
Tolterodine—Confusional state—Ifosfamide—testicular cancer	0.00172	0.00564	CcSEcCtD
Tolterodine—Abnormal vision—Doxorubicin—testicular cancer	0.00171	0.00561	CcSEcCtD
Tolterodine—Pain—Bleomycin—testicular cancer	0.00171	0.0056	CcSEcCtD
Tolterodine—Anaphylactic shock—Ifosfamide—testicular cancer	0.00171	0.0056	CcSEcCtD
Tolterodine—Oedema—Ifosfamide—testicular cancer	0.00171	0.0056	CcSEcCtD
Tolterodine—Anaphylactoid reaction—Methotrexate—testicular cancer	0.0017	0.00557	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Dactinomycin—testicular cancer	0.0017	0.00557	CcSEcCtD
Tolterodine—Asthenia—Vinblastine—testicular cancer	0.0017	0.00556	CcSEcCtD
Tolterodine—Infection—Ifosfamide—testicular cancer	0.0017	0.00556	CcSEcCtD
Tolterodine—Feeling abnormal—Bleomycin—testicular cancer	0.00165	0.0054	CcSEcCtD
Tolterodine—Diarrhoea—Vinblastine—testicular cancer	0.00162	0.00531	CcSEcCtD
Tolterodine—Fatigue—Dactinomycin—testicular cancer	0.00161	0.00527	CcSEcCtD
Tolterodine—Pain—Dactinomycin—testicular cancer	0.00159	0.00522	CcSEcCtD
Tolterodine—Anaphylactoid reaction—Epirubicin—testicular cancer	0.00159	0.00521	CcSEcCtD
Tolterodine—Dizziness—Vinblastine—testicular cancer	0.00156	0.00513	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.00156	0.0051	CcSEcCtD
Tolterodine—Feeling abnormal—Dactinomycin—testicular cancer	0.00153	0.00503	CcSEcCtD
Tolterodine—Anxiety—Cisplatin—testicular cancer	0.00153	0.00502	CcSEcCtD
Tolterodine—Gastrointestinal pain—Dactinomycin—testicular cancer	0.00152	0.005	CcSEcCtD
Tolterodine—Somnolence—Ifosfamide—testicular cancer	0.00152	0.00498	CcSEcCtD
Tolterodine—Vertigo—Etoposide—testicular cancer	0.00148	0.00487	CcSEcCtD
Tolterodine—Headache—Vinblastine—testicular cancer	0.00148	0.00486	CcSEcCtD
Tolterodine—Abdominal pain—Dactinomycin—testicular cancer	0.00147	0.00483	CcSEcCtD
Tolterodine—Fatigue—Ifosfamide—testicular cancer	0.00147	0.00483	CcSEcCtD
Tolterodine—Anaphylactic shock—Cisplatin—testicular cancer	0.00147	0.00483	CcSEcCtD
Tolterodine—Oedema—Cisplatin—testicular cancer	0.00147	0.00483	CcSEcCtD
Tolterodine—Hypersensitivity—Bleomycin—testicular cancer	0.00147	0.00483	CcSEcCtD
Tolterodine—Anaphylactoid reaction—Doxorubicin—testicular cancer	0.00147	0.00482	CcSEcCtD
Tolterodine—Infection—Cisplatin—testicular cancer	0.00146	0.00479	CcSEcCtD
Tolterodine—Constipation—Ifosfamide—testicular cancer	0.00146	0.00479	CcSEcCtD
Tolterodine—Pain—Ifosfamide—testicular cancer	0.00146	0.00479	CcSEcCtD
Tolterodine—Tachycardia—Cisplatin—testicular cancer	0.00144	0.00471	CcSEcCtD
Tolterodine—Asthenia—Bleomycin—testicular cancer	0.00143	0.0047	CcSEcCtD
Tolterodine—Dry skin—Epirubicin—testicular cancer	0.00141	0.00462	CcSEcCtD
Tolterodine—Feeling abnormal—Ifosfamide—testicular cancer	0.00141	0.00461	CcSEcCtD
Tolterodine—Chest pain—Etoposide—testicular cancer	0.00141	0.00461	CcSEcCtD
Tolterodine—Gastrointestinal pain—Ifosfamide—testicular cancer	0.0014	0.00458	CcSEcCtD
Tolterodine—Hypersensitivity—Dactinomycin—testicular cancer	0.00137	0.0045	CcSEcCtD
Tolterodine—Confusional state—Etoposide—testicular cancer	0.00136	0.00446	CcSEcCtD
Tolterodine—Abdominal pain—Ifosfamide—testicular cancer	0.00135	0.00443	CcSEcCtD
Tolterodine—Anaphylactic shock—Etoposide—testicular cancer	0.00135	0.00442	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.00134	0.0044	CcSEcCtD
Tolterodine—Infection—Etoposide—testicular cancer	0.00134	0.00439	CcSEcCtD
Tolterodine—Asthenia—Dactinomycin—testicular cancer	0.00134	0.00438	CcSEcCtD
Tolterodine—Dysuria—Methotrexate—testicular cancer	0.00133	0.00435	CcSEcCtD
Tolterodine—Upper respiratory tract infection—Methotrexate—testicular cancer	0.00132	0.00433	CcSEcCtD
Tolterodine—Tachycardia—Etoposide—testicular cancer	0.00132	0.00432	CcSEcCtD
Tolterodine—Dry skin—Doxorubicin—testicular cancer	0.0013	0.00428	CcSEcCtD
Tolterodine—Bronchitis—Epirubicin—testicular cancer	0.00128	0.00419	CcSEcCtD
Tolterodine—Diarrhoea—Dactinomycin—testicular cancer	0.00127	0.00418	CcSEcCtD
Tolterodine—Pain—Cisplatin—testicular cancer	0.00126	0.00413	CcSEcCtD
Tolterodine—Hypersensitivity—Ifosfamide—testicular cancer	0.00126	0.00412	CcSEcCtD
Tolterodine—Dysuria—Epirubicin—testicular cancer	0.00124	0.00408	CcSEcCtD
Tolterodine—Upper respiratory tract infection—Epirubicin—testicular cancer	0.00124	0.00405	CcSEcCtD
Tolterodine—Asthenia—Ifosfamide—testicular cancer	0.00122	0.00402	CcSEcCtD
Tolterodine—Feeling abnormal—Cisplatin—testicular cancer	0.00121	0.00398	CcSEcCtD
Tolterodine—Weight increased—Epirubicin—testicular cancer	0.00121	0.00397	CcSEcCtD
Tolterodine—Somnolence—Etoposide—testicular cancer	0.0012	0.00393	CcSEcCtD
Tolterodine—Bronchitis—Doxorubicin—testicular cancer	0.00118	0.00388	CcSEcCtD
Tolterodine—Diarrhoea—Ifosfamide—testicular cancer	0.00117	0.00383	CcSEcCtD
Tolterodine—Fatigue—Etoposide—testicular cancer	0.00116	0.00381	CcSEcCtD
Tolterodine—Pain—Etoposide—testicular cancer	0.00115	0.00378	CcSEcCtD
Tolterodine—Constipation—Etoposide—testicular cancer	0.00115	0.00378	CcSEcCtD
Tolterodine—Urinary tract infection—Epirubicin—testicular cancer	0.00115	0.00378	CcSEcCtD
Tolterodine—Dysuria—Doxorubicin—testicular cancer	0.00115	0.00377	CcSEcCtD
Tolterodine—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.00114	0.00375	CcSEcCtD
Tolterodine—Dizziness—Ifosfamide—testicular cancer	0.00113	0.0037	CcSEcCtD
Tolterodine—Weight increased—Doxorubicin—testicular cancer	0.00112	0.00367	CcSEcCtD
Tolterodine—Sinusitis—Epirubicin—testicular cancer	0.00111	0.00365	CcSEcCtD
Tolterodine—Feeling abnormal—Etoposide—testicular cancer	0.00111	0.00364	CcSEcCtD
Tolterodine—Gastrointestinal pain—Etoposide—testicular cancer	0.0011	0.00362	CcSEcCtD
Tolterodine—Visual impairment—Methotrexate—testicular cancer	0.0011	0.00359	CcSEcCtD
Tolterodine—Hypersensitivity—Cisplatin—testicular cancer	0.00108	0.00356	CcSEcCtD
Tolterodine—Abdominal pain—Etoposide—testicular cancer	0.00107	0.0035	CcSEcCtD
Tolterodine—Urinary tract infection—Doxorubicin—testicular cancer	0.00107	0.0035	CcSEcCtD
Tolterodine—Asthenia—Cisplatin—testicular cancer	0.00106	0.00346	CcSEcCtD
Tolterodine—Oedema peripheral—Epirubicin—testicular cancer	0.00105	0.00344	CcSEcCtD
Tolterodine—Sinusitis—Doxorubicin—testicular cancer	0.00103	0.00337	CcSEcCtD
Tolterodine—Visual impairment—Epirubicin—testicular cancer	0.00103	0.00336	CcSEcCtD
Tolterodine—Diarrhoea—Cisplatin—testicular cancer	0.00101	0.0033	CcSEcCtD
Tolterodine—Hypersensitivity—Etoposide—testicular cancer	0.000993	0.00326	CcSEcCtD
Tolterodine—Flushing—Epirubicin—testicular cancer	0.000987	0.00324	CcSEcCtD
Tolterodine—Oedema peripheral—Doxorubicin—testicular cancer	0.00097	0.00318	CcSEcCtD
Tolterodine—Asthenia—Etoposide—testicular cancer	0.000967	0.00317	CcSEcCtD
Tolterodine—Visual impairment—Doxorubicin—testicular cancer	0.000948	0.00311	CcSEcCtD
Tolterodine—Diarrhoea—Etoposide—testicular cancer	0.000922	0.00303	CcSEcCtD
Tolterodine—Flushing—Doxorubicin—testicular cancer	0.000913	0.003	CcSEcCtD
Tolterodine—Flatulence—Epirubicin—testicular cancer	0.000912	0.00299	CcSEcCtD
Tolterodine—Dizziness—Etoposide—testicular cancer	0.000891	0.00292	CcSEcCtD
Tolterodine—Vertigo—Methotrexate—testicular cancer	0.000889	0.00292	CcSEcCtD
Tolterodine—Headache—Etoposide—testicular cancer	0.000845	0.00277	CcSEcCtD
Tolterodine—Flatulence—Doxorubicin—testicular cancer	0.000844	0.00277	CcSEcCtD
Tolterodine—Arthralgia—Methotrexate—testicular cancer	0.000842	0.00276	CcSEcCtD
Tolterodine—Chest pain—Methotrexate—testicular cancer	0.000842	0.00276	CcSEcCtD
Tolterodine—Vertigo—Epirubicin—testicular cancer	0.000832	0.00273	CcSEcCtD
Tolterodine—Palpitations—Epirubicin—testicular cancer	0.000818	0.00268	CcSEcCtD
Tolterodine—Confusional state—Methotrexate—testicular cancer	0.000814	0.00267	CcSEcCtD
Tolterodine—Anaphylactic shock—Methotrexate—testicular cancer	0.000808	0.00265	CcSEcCtD
Tolterodine—Infection—Methotrexate—testicular cancer	0.000802	0.00263	CcSEcCtD
Tolterodine—Arthralgia—Epirubicin—testicular cancer	0.000788	0.00259	CcSEcCtD
Tolterodine—Chest pain—Epirubicin—testicular cancer	0.000788	0.00259	CcSEcCtD
Tolterodine—Anxiety—Epirubicin—testicular cancer	0.000786	0.00258	CcSEcCtD
Tolterodine—Dry mouth—Epirubicin—testicular cancer	0.000771	0.00253	CcSEcCtD
Tolterodine—Vertigo—Doxorubicin—testicular cancer	0.00077	0.00252	CcSEcCtD
Tolterodine—Confusional state—Epirubicin—testicular cancer	0.000762	0.0025	CcSEcCtD
Tolterodine—Palpitations—Doxorubicin—testicular cancer	0.000757	0.00248	CcSEcCtD
Tolterodine—Anaphylactic shock—Epirubicin—testicular cancer	0.000756	0.00248	CcSEcCtD
Tolterodine—Oedema—Epirubicin—testicular cancer	0.000756	0.00248	CcSEcCtD
Tolterodine—Infection—Epirubicin—testicular cancer	0.000751	0.00246	CcSEcCtD
Tolterodine—Tachycardia—Epirubicin—testicular cancer	0.000738	0.00242	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000736	0.00241	CcSEcCtD
Tolterodine—Chest pain—Doxorubicin—testicular cancer	0.000729	0.00239	CcSEcCtD
Tolterodine—Arthralgia—Doxorubicin—testicular cancer	0.000729	0.00239	CcSEcCtD
Tolterodine—Anxiety—Doxorubicin—testicular cancer	0.000727	0.00238	CcSEcCtD
Tolterodine—Somnolence—Methotrexate—testicular cancer	0.000718	0.00235	CcSEcCtD
Tolterodine—Dry mouth—Doxorubicin—testicular cancer	0.000713	0.00234	CcSEcCtD
Tolterodine—Dyspepsia—Methotrexate—testicular cancer	0.000711	0.00233	CcSEcCtD
Tolterodine—Confusional state—Doxorubicin—testicular cancer	0.000705	0.00231	CcSEcCtD
Tolterodine—Anaphylactic shock—Doxorubicin—testicular cancer	0.000699	0.00229	CcSEcCtD
Tolterodine—Oedema—Doxorubicin—testicular cancer	0.000699	0.00229	CcSEcCtD
Tolterodine—Fatigue—Methotrexate—testicular cancer	0.000696	0.00228	CcSEcCtD
Tolterodine—Infection—Doxorubicin—testicular cancer	0.000695	0.00228	CcSEcCtD
Tolterodine—Pain—Methotrexate—testicular cancer	0.000691	0.00226	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000688	0.00226	CcSEcCtD
Tolterodine—Tachycardia—Doxorubicin—testicular cancer	0.000682	0.00224	CcSEcCtD
Tolterodine—Somnolence—Epirubicin—testicular cancer	0.000672	0.0022	CcSEcCtD
Tolterodine—Feeling abnormal—Methotrexate—testicular cancer	0.000665	0.00218	CcSEcCtD
Tolterodine—Dyspepsia—Epirubicin—testicular cancer	0.000665	0.00218	CcSEcCtD
Tolterodine—Gastrointestinal pain—Methotrexate—testicular cancer	0.00066	0.00217	CcSEcCtD
Tolterodine—Fatigue—Epirubicin—testicular cancer	0.000652	0.00214	CcSEcCtD
Tolterodine—Pain—Epirubicin—testicular cancer	0.000646	0.00212	CcSEcCtD
Tolterodine—Constipation—Epirubicin—testicular cancer	0.000646	0.00212	CcSEcCtD
Tolterodine—Abdominal pain—Methotrexate—testicular cancer	0.000638	0.00209	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000637	0.00209	CcSEcCtD
Tolterodine—Feeling abnormal—Epirubicin—testicular cancer	0.000623	0.00204	CcSEcCtD
Tolterodine—Somnolence—Doxorubicin—testicular cancer	0.000622	0.00204	CcSEcCtD
Tolterodine—Gastrointestinal pain—Epirubicin—testicular cancer	0.000618	0.00203	CcSEcCtD
Tolterodine—Dyspepsia—Doxorubicin—testicular cancer	0.000616	0.00202	CcSEcCtD
Tolterodine—Fatigue—Doxorubicin—testicular cancer	0.000603	0.00198	CcSEcCtD
Tolterodine—Pain—Doxorubicin—testicular cancer	0.000598	0.00196	CcSEcCtD
Tolterodine—Constipation—Doxorubicin—testicular cancer	0.000598	0.00196	CcSEcCtD
Tolterodine—Abdominal pain—Epirubicin—testicular cancer	0.000597	0.00196	CcSEcCtD
Tolterodine—Hypersensitivity—Methotrexate—testicular cancer	0.000595	0.00195	CcSEcCtD
Tolterodine—Asthenia—Methotrexate—testicular cancer	0.000579	0.0019	CcSEcCtD
Tolterodine—Feeling abnormal—Doxorubicin—testicular cancer	0.000576	0.00189	CcSEcCtD
Tolterodine—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000572	0.00188	CcSEcCtD
Tolterodine—Hypersensitivity—Epirubicin—testicular cancer	0.000557	0.00183	CcSEcCtD
Tolterodine—Abdominal pain—Doxorubicin—testicular cancer	0.000553	0.00181	CcSEcCtD
Tolterodine—Diarrhoea—Methotrexate—testicular cancer	0.000553	0.00181	CcSEcCtD
Tolterodine—Asthenia—Epirubicin—testicular cancer	0.000542	0.00178	CcSEcCtD
Tolterodine—Dizziness—Methotrexate—testicular cancer	0.000534	0.00175	CcSEcCtD
Tolterodine—Diarrhoea—Epirubicin—testicular cancer	0.000517	0.0017	CcSEcCtD
Tolterodine—Hypersensitivity—Doxorubicin—testicular cancer	0.000515	0.00169	CcSEcCtD
Tolterodine—Headache—Methotrexate—testicular cancer	0.000506	0.00166	CcSEcCtD
Tolterodine—Asthenia—Doxorubicin—testicular cancer	0.000502	0.00165	CcSEcCtD
Tolterodine—Dizziness—Epirubicin—testicular cancer	0.0005	0.00164	CcSEcCtD
Tolterodine—Diarrhoea—Doxorubicin—testicular cancer	0.000478	0.00157	CcSEcCtD
Tolterodine—Headache—Epirubicin—testicular cancer	0.000473	0.00155	CcSEcCtD
Tolterodine—Dizziness—Doxorubicin—testicular cancer	0.000462	0.00152	CcSEcCtD
Tolterodine—Headache—Doxorubicin—testicular cancer	0.000438	0.00144	CcSEcCtD
